Impact of erythropoietin on arterial hypertension

Abstract

Cardiovascular and renal diseases constitute two pathophysiological contexts of progressive fatal recognitions worldwide and as priorities in terms of health in its entirety. Erythropoietin is a glycoprotein hormone which produces red blood cells, which carry oxygen in the blood. The objective was to know the most prevalent modifiable risk factors found in arterial hypertension, since this disease is the third cause of death in the world, the bibliographic search and the inductive-deductive method were used. The result was that treatment with recombinant human erythropoietin-stimulating agents is considered effective in improving the management of anemia associated with chronic kidney disease, since it has cardioprotective, renoprotective and neuroprotective functions.

Health poverty, educational capital and industrial integration of rural households

“…However, it must not be overlooked that it plays an important role in the integration of the three industries and the revitalization of the countryside. After being fully lifted out of poverty, farmers' subjective status was guaranteed and their own identity changed, which in turn led to a significant increase in their subjective motivation, which is crucial for poverty return interdiction and rural revitalization (Loor et al, 2020;Manrique et al, 2020;Suryasa, Rodríguez-Gámez, Herrera, et al, 2022).…”